Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
Insight Molecular Diagnostics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Insight Molecular Diagnostics's enterprise value was $60.21M on Nov 11, 2026, against $157.07M a year earlier. Over the last 5 years it ranged from $1.46M to $196.00M, with a median of $41.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $60.21M | -69.3% |
| 2025 | Dec 31, 2025 | $196.00M | +588.5% |
| 2024 | Dec 31, 2024 | $28.47M | +314.4% |
| 2023 | Dec 29, 2023 | $6.87M | +14.3% |
| 2022 | Dec 30, 2022 | $6.01M | -96.2% |
| 2021 | Dec 31, 2021 | $156.64M | +4.1% |
| 2020 | Dec 31, 2020 | $150.44M | +54.3% |
| 2019 | Dec 31, 2019 | $97.50M | +115.2% |
| 2018 | Dec 31, 2018 | $45.30M | -66.5% |
| 2017 | Dec 29, 2017 | $135.07M | -28.7% |
| 2016 | Dec 30, 2016 | $189.50M | +67.0% |
| 2015 | Dec 31, 2015 | $113.49M | – |
See a number that looks wrong?